JPT1 and breast carcinoma: Recently, Zhanguo Zhang and colleagues find miR-132 can inhibit cell proliferation, invasion, migration and metastasis of breast cancer by targeting HN1 [14], but the role of HN1 in breast cancer and its regulatory mechanism have not been well documented.